Muvalaplin is a small molecule drug. Muvalaplin is under investigation in clinical trial NCT05563246 (A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events). Muvalaplin has a monoisotopic molecular weight of 710.4 Da. Other names for this substance include Muvalaplina and Muvalapline. Its PubChem CID is 155369486.
Muvalaplin
| CAS No | 2565656-70-2 |
|---|---|
| Molecular Formula | C42H54N4O6 |
| Molecular Weight | 710.9 g/mol |
| Synonyms | (2S)-3-[3-[[bis[[3-[(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl]phenyl]methyl]amino]methyl]phenyl]-2-[(3R)-pyrrolidin-3-yl]propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Muvalaplin is a small molecule drug. Muvalaplin is under investigation in clinical trial NCT05563246 (A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events).
The listed CAS number is 2565656-70-2.
The listed molecular formula is C42H54N4O6.
The listed molecular weight is 710.9 g/mol.
(2S)-3-[3-[[bis[[3-[(2S)-2-carboxy-2-[(3R)-pyrrolidin-3-yl]ethyl]phenyl]methyl]amino]methyl]phenyl]-2-[(3R)-pyrrolidin-3-yl]propanoic acid.
The source lists Muvalaplina and Muvalapline.